0001729214-24-000001.txt : 20241031 0001729214-24-000001.hdr.sgml : 20241031 20241031102813 ACCESSION NUMBER: 0001729214-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241031 DATE AS OF CHANGE: 20241031 EFFECTIVENESS DATE: 20241031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XORTX Therapeutics Inc. CENTRAL INDEX KEY: 0001729214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-528293 FILM NUMBER: 241412893 BUSINESS ADDRESS: STREET 1: SUITE 2400 - 745 THURLOW STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 0C5 BUSINESS PHONE: 403-607-2621 MAIL ADDRESS: STREET 1: SUITE 2400 - 745 THURLOW STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 0C5 D 1 primary_doc.xml X0708 D LIVE 0001729214 XORTX Therapeutics Inc. 3710 - 33rd Street NW Calgary A0 ALBERTA, CANADA T2L 2M1 403-455-7727 BRITISH COLUMBIA, CANADA APAC Resources Inc. None Corporation true Allen Davidoff 3710 - 33rd Street NW Calgary A0 ALBERTA, CANADA T2L 2M1 Executive Officer Director Stacy Evans 3710 - 33rd Street NW Calgary A0 ALBERTA, CANADA T2L 2M1 Executive Officer James Fairbairn 3710 - 33rd Street NW Calgary A0 ALBERTA, CANADA T2L 2M1 Executive Officer Stephen Haworth 3710 - 33rd Street NW Calgary A0 ALBERTA, CANADA T2L 2M1 Executive Officer William Farley 3710 - 33rd Street NW Calgary A0 ALBERTA, CANADA T2L 2M1 Director Anthony J. Giovinazzo 3710 - 33rd Street NW Calgary A0 ALBERTA, CANADA T2L 2M1 Director Abigail Jenkins 3710 - 33rd Street NW Calgary A0 ALBERTA, CANADA T2L 2M1 Director Raymond Pratt 3710 - 33rd Street NW Calgary A0 ALBERTA, CANADA T2L 2M1 Director Patrick Treanor 3710 - 33rd Street NW Calgary A0 ALBERTA, CANADA T2L 2M1 Director Paul Van Damme 3710 - 33rd Street NW Calgary A0 ALBERTA, CANADA T2L 2M1 Director Other Decline to Disclose 06b false 2024-10-18 true true true true true One warrant entitles the holder thereof to purchase one common share of the Company at an exercise price of US$2.18 per share for a period of five years following the issuance of the warrants. false 0 A.G.P./Alliance Global Partners 8361 None None 88 Post Road West Floor 2 Westport CT CONNECTICUT 06880 NY NEW YORK false 1767566 0 1767566 The $1,767,566 may be received upon the exercise of share purchase warrants sold inside and outside the U.S. false 1 105000 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false XORTX Therapeutics Inc. /s/ Allen Davidoff Allen Davidoff Chief Executive Officer 2024-10-30